Data
suggesting that Tpl2 ablation promotes the Th2 polarization of the T cell response. Anti-CD3 stimulation of CD4 + T cells of wildtype and Tpl2 knockout mice revealed that Tpl2 ablation gives rise to a cell autonomous T cell defect that is primarily responsible for the Th2 polarization of the T cell response to Ag. T helper cells differentiate in response to external signals toward Th1, Th2, and Th17 cells. The differentiation depends on epigenetically controlled global changes in gene expression and it is regulated by cytokines and chemokines produced by T cells or other hematopoietic cells and the signaling pathways they activate (1) . Th1 cells produce IFN-g, are involved in cellmediated immunity, and contribute to the defense against intracellular bacteria, viruses, and tumor cells. Th2 cells produce IL-4, IL-5, and IL-13, are involved in humoral immunity, and contribute to the defense against extracellular parasites. Th17 cells produce IL-17, activate neutrophils, and contribute to the defense against bacteria at mucosal sites (2) (3) (4) . Our understanding of the mechanisms responsible for the polarization of the Th cell response toward Th1, Th2, and Th17 depends, to a significant degree, on the successful exploitation of animal genetic models (5) .
The work presented in this paper uses Tpl2 2/2 mice to determine the role of the Tpl2 kinase in the polarization of the Th cell response in animals exposed to OVA. Animals immunized by i.p. injection of OVA in an alum formulation, make Abs that belong to different isotype subclasses, including IgG1 and IgE (6) . When challenged by OVA administered intranasally, immunized animals develop bronchoalveolar inflammation (7) (8) (9) (10) . The severity of inflammation depends on the level of IgE in the serum and the main cell type in the inflammatory exudates is the eosinophil (8, 11) . The role of IgE in allergen-induced bronchoalveolar inflammation has been inferred from numerous epidemiologic studies demonstrating a relationship between asthma and IgE levels (12, 13) , and from human and animal studies showing that anti-IgE immunotherapy can improve the clinical course of asthma (14) (15) (16) . Functional studies provided evidence that IgE binds its high-affinity receptor Fc-e-RI (17) and contributes to mast cell degranulation and release of potent proinflammatory mediators, such as histamine and leukotrienes (18, 19) . Ig isotype switching toward IgE depends on costimulatory molecules and cytokines expressed by the APCs (20) , as well as cytokines produced by T cells during the immune response. T cell cytokines that shift the Ig isotype balance toward IgE and promote bronchial inflammation include the Th2-type cytokines IL-4 and IL-5 (8, 9, 21) . These cytokines play very important roles in OVAinduced bronchoalveolar inflammation in both animal models and in humans (8, 9, (21) (22) (23) (24) . In addition to its role in the polarization of the Th cell response, IL-5 contributes to the recruitment of eosinophils. For this, it operates in concert with eotaxin, an eosinophil chemoattractant that is produced by endothelial and alveolar epithelial cells (25, 26) . IL-5 mobilizes eosinophils from the marrow and increases their sensitivity to eotaxin (27) , whereas eotaxin targets the accumulation of eosinophils at specific sites (25, 28, 29) .
Tpl2 is a serine-threonine protein kinase that, when overexpressed, activates all the MAP kinase pathways (30) (31) (32) , and the transcription factors NFAT and NF-kB in a variety of cell types (33) (34) (35) . Tpl2 ablation in mice revealed an obligatory role for this kinase in the transduction of TLR, death receptor, and G-protein-coupled receptor signals (36) (37) (38) (39) . However, of the pathways activated by these signals in macrophages and dendritic cells, only ERK depends on Tpl2 (40) . The loss of ERK activation renders Tpl2 2/2 macrophages defective in the induction of TNF-a and other proinflammatory molecules. These findings suggest that Tpl2 is involved in the regulation of innate immunity (36) (37) (38) 40) . Tpl2 also plays an important role in T cell function and the regulation of adaptive immunity. TCR-stimulated Tpl2 2/2 T cells exhibit a defect in ERK activation and CTLA4 induction and they hyperproliferate in response to Ag (41) . In this paper we present evidence that OVA-immunized Tpl2 
Materials and Methods

Animals
Tpl2 knockout mice have been described previously (30, 36) . These mice carry a partial deletion of exon 3, a complete deletion of intron 3, exon 4, and intron 4, and a partial deletion of exon 5. The deletion removed the sequences encoding the ATP binding site of the Tpl2 kinase, and gave rise to a mutant gene that fails to produce stable RNA or protein (36) . Experimental mice were 6-to 8-wk-old male littermates, and they were generated by crossing heterozygous Tpl2 2/+ mice. The Tpl2 2/2 mice used in these experiments had been backcrossed nine times to C57BL/6 mice. OT2 transgenic mice carry a TCR transgene that recognizes the OVA peptide OVA 323-339 (43) . Tpl2 2/2 /OT2 transgenic C57BL/6 mice were produced by crossing the OT2 transgene (also on the C57BL/6 background) into the Tpl2 2/2 genetic background. All mice were housed under pathogen-free conditions. All animal studies were approved by the Institutional Animal Care and Use Committees (IACUC) in the authors' institutions.
Ag sensitization and challenge
Mice were inoculated i.p. with 10 mg OVA (Sigma-Aldrich, St. Louis, MO) in 100 ml PBS/alum suspension or with an equivalent volume of PBS/alum on days 0 and 5. The OVA inoculum was prepared by mixing OVA dissolved in PBS at a concentration of 200 mg/ml, with an equal volume of a 2 mg/ml Alum suspension (Sigma-Aldrich). The final concentration of OVA in the 100 ml OVA inoculum was 100 mg/ml and the final concentration of alum was 1 mg/ml. Seven days after the 5-d boost, mice received 100 mg OVA dissolved in 30 ml PBS intranasally. Intranasal OVA application was repeated daily for 3 d. Prior to the intranasal application of the Ag, the mice were anesthetized with isoflurane (Abbott Laboratories, Abbott Park, IL).
Bronchoalveolar exudates
Bronchoalveolar exudates were collected by bronchoalveolar lavage (BAL) 1 d after the last intranasal application of OVA. Mice were anesthetized by i.p. injection of 2 mg pentobarbital (Abbott Laboratories). After this, their tracheas were cannulated with a polyethylene catheter (20 gauge; 1.16 inch), and their lungs were lavaged twice with 0.6 ml PBS. The volume recovered from each animal was ∼0.8 ml. Cells in the recovered BAL were counted in a hemocytometer. Cytospin preparations of BAL were stained with Wright's stain (Protocol HEMA 3, Biochemical Science, Swedesboro, NJ). BAL supernatants obtained by centrifugation were used to measure eosinophil peroxidase, eotaxin, IgE, and cytokine (IL-4 and IL-5) levels.
Measurement of anti-OVA IgG1, IgE, and total IgE in serum and BAL Ninety-six-well microtiter plates were coated with a purified anti-mouse IgE mAb (R35-72, BD Pharmingen, San Diego, CA). Undiluted BAL or dilutions of serum samples were then added to the coated plates. The captured IgE was detected either with a biotinylated anti-mouse IgE mAb (R35-92, BD Pharmingen) or with biotinylated-OVA (40 mg/ml). The IgE Ab measured total IgE levels, whereas OVA measured IgE-specific anti-OVA Abs. The total IgE levels were calculated based on standard curves generated from known amounts of purified mouse IgE (k isotype standard, [anti-TNP], 03121D, BD Pharmingen). OVA-specific IgG1 Abs were measured in serum samples using standard ELISA protocols. Microtiter plates were coated with OVA (10 mg/ml). Dilutions of serum samples were then added to the plates. Biotinylated mAbs against mouse IgG1 (A85-1, BD Pharmingen) were used for detection. The levels of anti-OVA IgG1 were expressed as relative OD values.
Quantitation and functional analysis of mast cells and basophils
Quantitation of mast cells in vivo was performed by staining sections of skin and stomach with toluidine blue at low pH. The numbers of brightly stained mast cells were counted per field of view for skin and per section for stomach. Basophils are characterized as FcΕRI + Kit 2 CD11b + CD49b + cells and were quantified in blood and spleen as described previously (44) .
Bone marrow-derived mast cells (BMMCs) were obtained by flushing bone marrow cells from mouse tibiae and femurs with media and culturing them with recombinant mouse IL-3 (20 ng/ml) and stem cell factor (20 ng/ml) for .1 mo. IgE receptor expression was determined by flow cytometry using FITC-conjugated anti-mouse IgE or an isotype control Ab (BD Pharmingen).
To test for BMMC function, Ag-induced b-hexosaminidase was measured. Briefly, 2 3 10 6 BMMCs/ml were sensitized in medium without IL-3 for 3 h with 1 mg/ml of DNP-specific IgE and challenged with DNP-HSA at 1-1000 ng/ml in Tyrode's buffer (10 mM HEPES buffer [pH 7.4], 130 mM NaCl, 5 mM KCl, 1.4 mM CaCl 2 , 1 mM MgCl 2 , 5.6 mM glucose, and 0.1% BSA). b-hexosaminidase release was measured as described previously (45) . The enzymatic activities of b-hexosaminidase in supernatants and in the cell pellets, after solubilizing with 0.5% Triton X-100 in Tyrode's buffer, were measured with p-nitrophenyl N-acetyl-b-D-glucosaminide in 0.1 M sodium citrate (pH 4.5) for 60 min at 37˚C. The reaction was stopped by addition of 0.2 M glycine (pH 10.7). The release of the product 4-p-nitrophenol was detected by absorbance at 405 nm. The extent of degranulation was calculated as the percentage of 4-p-nitrophenol absorbance in the supernatants over the sum of absorbance in the supernatants and in cell pellets solubilized in detergent. For maximal IgE-independent b-hexosaminidase release, cells were alternatively stimulated with PMA plus ionomycin.
Splenocyte cultures, bone marrow-derived dendritic cells, and CD4 + T cells
Single-cell suspensions of mouse splenocytes (2 3 10 7 cells/ml) derived from Tpl2 +/+ and Tpl2 2/2 mice were cultured in DMEM supplemented with penicillin and streptomycin (Life Technologies, Rockville, MD), nonessential amino acids (Life Technologies), sodium pyruvate (Life Technologies), and FBS (10%, Life Technologies). Splenocyte cultures were treated with OVA (100 mg/ml) for 48 h. Culture supernatants were tested for IL-4, IL-5, and IFN-g by ELISA.
Bone marrow-derived dendritic cells (BMDCs) were produced by culture of bone marrow cells from femurs and tibias of six 12-wk-old mice. Cells (1 3 10 6 cells/ml) were cultured at 37˚C and 5% CO 2 in complete RPMI (RPMI 1640 containing 10% FCS [BioSource International, Camarillo, CA], 100 U/ml penicillin, 100 mg/ml streptomycin, 2 mM L-glutamine [Invitrogen] , and 50 mM 2-mercaptoethanol [Sigma-Aldrich]) supplemented with 40 ng/ml GM-CSF (PeproTech, Rocky Hill, NJ). On days 3 and 5, fresh medium equal to half of the initial volume of the culture containing 40 ng/ml GM-CSF was added. On day 7, nonadherent cells were collected, incubated with anti-mouse CD11c labeled microbeads (Miltenyi Biotech, Auburn, CA), and CD11c + cells were selected using an AutoMACS (Miltenyi Biotec) according to the manufacturer's instructions. The purity of the cell population was determined to be .90% CD11c + by flow cytometry. To determine whether LPS-stimulated cells express dendritic cell markers, on day 6 of culture, cells were either stimulated with LPS, zymosan, or polyinosinic-polycytidylic acid overnight. On day 7, cells were harvested and stained with Abs to CD11c (HL-3, BD Pharmingen) and CD11b (M1/70, BD Pharmingen) in combination with Abs against costimulatory markers, including CD86 (GL1, BD Pharmingen), MHC class II/ I-A b (25-9-17, BD Pharmingen), CD40 (HM40-3, BD Pharmingen), and CD80 (16-10A1,BD Pharmingen).
Total CD4 + T cells were purified from spleen and lymph nodes by negative selection using a CD4 + T cell isolation kit and an AutoMACS instrument (Miltenyi Biotec). Cells isolated in this way were routinely .90% pure CD4 Anti-CD3 stimulation of total splenocytes and CD4 + T cells
For cytokine secretion, 5 3 10 5 whole splenocytes were stimulated in a 200-ml volume with 0-3 mg/ml anti-CD3 for 48 h, and IFN-g and IL-4 in cell culture supernatants were quantified by Th1/2 mouse cytometric bead array (BD Pharmingen). For mRNA analysis, 1-2 3 10 6 cells/ml were stimulated with 5 mg/ml immobilized anti-CD3, or 5 mg/ml immobilized anti-CD3 and anti-CD28 for 18 h. Gene expression was measured by realtime PCR. Briefly, RNA was isolated and reverse transcribed using a firststrand cDNA synthesis kit (Roche, Mannheim, Germany). Real-time PCR was performed using the ABI PRISM7700 Sequence Detection System (Applied Biosystems, Foster City, CA). Analysis of IL-4, IFN-g, and 18S mRNA levels was performed using commercially available primer/probe sets (Applied Biosystems). Relative levels of all genes were determined by normalization to endogenous 18S levels and are presented as relative to the unstimulated control for each individual experiment, which was arbitrarily designated a value of 1.
Th1 and Th2 differentiation of CD4
+ T cells and maintenance of Th1 and Th2 polarized cultures
2 T cells were sorted to .99% purity. Cells were cultured at 1 3 10 6 /ml complete RPMI 1640 in tissue culture plates that had been precoated with 5 mg/ml anti-CD3 and anti-CD28 in the presence of various cytokines and anticytokine Ab mixtures to direct distinct Th lineages as follows: Th0, no cytokines or anticytokines; Th1, 20 ng/ml IL-12 and 10 mg/ml anti-IL-4; and Th2, 10 ng/ml IL-4 and 10 mg/ml anti-IFN-g. Cells were cultured for 3 d and subsequently transferred into T75 flasks containing 15 ml medium with 40 U/ml IL-2 alone (Th0) or in combination with IL-12 (Th1) or IL-4 (Th2) and grown an additional 4 d. Fully polarized Th0, Th1, or Th2 cells were harvested after 7 d of culture.
For biochemical analyses of fully polarized wild-type (WT) and Tpl2
2/2
Th cell lineages, T cells were harvested on day 7 of culture. Cells were washed in complete RPMI 1640 and rested for 8 h in cytokine-free medium. After harvest, cells were adjusted to 2.5 3 10 6 cells/ml medium and stimulated with 5 mg/ml anti-CD3 for the indicated times. Lysates of cell pellets were prepared in Triton lysis buffer. Proteins were separated by SDS-PAGE and transferred to nylon membranes for Western blotting with phosphor ERK1/2 and total ERK1/2 Abs (Cell Signaling Technology, Beverly, MA) as previously described (36) .
For quantitation of transcription factor expression, total CD4 cells were subjected to the same 7-d Th0, Th1, and Th2 polarization regimen as described previously. On day 7, cells pellets were lysed in Triton lysis buffer. Proteins were separated by SDS-PAGE, transferred to nylon membranes, and probed for the Th1 transcription factor, T-bet (Santa Cruz Biotechnology, Santa Cruz, CA) as well as the Th2 transcription factor, Gata-3 (Santa Cruz Biotechnology) as previously described (36) .
OVA stimulation of mixed cultures of T cells and dendritic cells
For coculture experiments, 10 4 WT or Tpl2 2/2 BMDCs (10,000/well) were incubated with a 10-fold excess of naive OT2 CD4 + cells (100,000/well) and varying amounts of OVA peptide (OVA 323-339 , Peptides International, Louisville, KY) in 96-well microtiter plates in a volume of 200 mL. On day 3, supernatants were harvested and analyzed by ELISA for the expression of IFN-g, IL-4, and IL-5 as described below.
Measurement of cytokines, chemokines, and eosinophil peroxidase
To measure IL-4, IL-5, and IFN-g, in BAL and/or culture supernatants, we used ELISA kits from BD Pharmingen (OptEIA Kit). Alternatively, IFN-g and IL-4 were measured in cell culture supernatants using a mouse Th1/2 cytometric bead array (BD Pharmingen) where indicated.
Eotaxin levels were also measured by ELISA. The capture Ab, used to coat the microtiter plates, was an anti-mouse eotaxin polyclonal Ab (AF-420-NA, R&D Systems, Minneapolis, MN). The detection Ab was a biotinylated antimouse eotaxin Ab (BAF420, R&D Systems). Purified anti-mouse eotaxin Ab (the capture Ab) was diluted in coating buffer (0.4 mg/ml) and was adsorbed onto the wells of a 96-well microtiter plate. Uncoated sites were blocked with blocking buffer. The undiluted BAL samples were then incubated with the plate-bound antieotaxin Ab. After this, 40 ng/ml biotinylated anti-mouse eotaxin Ab (detection Ab) in blocking buffer was added to each well, followed by Avidin conjugated to HRP (BD Pharmingen) (1/ 1000 dilution), and the substrate 3,39,5.59tetramethylbenzidine (BD Pharmingen). Eotaxin levels were calculated by reference to standard curves of known amounts of recombinant mouse eotaxin (420-ME, R&D Systems).
Eosinophil peroxidase in BAL was measured using o-phenylene-diamine hydrochloride as the substrate. Seventy-five microliters of the substrate solution (16 mM o-phenylene-diamine hydrochloride, 0.1% Triton X-100, 0.01% H 2 O 2 in 100 mM Tris-HCl) was added to 50 ml of the sample in 96-well microtiter plates and the mixture was incubated at room temperature for 30 min. The reaction was stopped by adding 50 ml 4 M sulfuric acid. The OD of the reaction product was read at 450 nm. Eosinophil peroxidase levels were calculated by reference to standard curves of HRP (BD Pharmingen). This method has been shown to detect eosinophil but not neutrophil peroxidase activity (46) .
Statistical analysis
Given the variability between individual mice, all the experiments were carried out on multiple animals (3-11 per group per experiment), and they were repeated multiple (3-18) times. Tpl2 +/+ and Tpl2 2/2 mice within a given experiment were compared by t test or the Wilcoxon/Mann-Whitney U test, a nonparametric equivalent that does not assume normality of the measurements (it compares medians instead of means).
Results
Total IgE, Ag-specific IgG1, and IgE levels in the serum of OVA-immunized Tpl2 +/+ and Tpl2 2/2 mice
To determine the role of Tpl2 in adaptive immunity and allergeninduced pulmonary inflammation, Tpl2 +/+ and Tpl2 2/2 mice were inoculated i.p. with OVA (10 mg) in alum. The i.p. inoculation of the OVA/alum formulation elicits a response characterized by the production of IgG1 and IgE Abs. Five days later, the mice were given a boost of 10 mg OVA i.p. Finally, on days 12-14 the mice were challenged with the same Ag intranasally. One day after the intranasal challenge, blood samples were collected, and serum levels of total IgE and OVA-specific IgG1 and IgE were measured by ELISA. The results showed that serum levels of OVA-specific IgG1 Abs were lower in Tpl2 2/2 mice (Fig. 1A) . In contrast, total
IgE and OVA-specific IgE Abs were significantly higher in Tpl2 2/2 mice (Fig. 1B, 1C ). These results demonstrate that inactivation of Tpl2 enhances total and Ag-specific IgE responses. Our previous studies had shown that the histology of the bone marrow, thymus, spleen, and lymph nodes of the Tpl2 2/2 mice was normal and that the numbers of CD4, CD8, Thy1.2, B220, CD11b, Ter-1 (CCR8), CD3, IL-2Ra, TCRa/b, and TCRg/d positive cells in these organs, were also normal (36) . These findings suggest that the shift in the relative levels of Ig isotypes observed in OVAimmunized Tpl2 2/2 mice were not due to major structural defects of these organs or to major defects in lymphoid cell differentiation and distribution. Our previous studies had also shown that isolated B cells from Tpl2 2/2 mice produced low levels of IgE when stimulated with IL-4 or CD40 ligand, two molecules that control IgE synthesis in B cells (47) . The increased levels of IgE in OVAimmunized mice therefore were unexpected and could not be explained on the basis of a cell autonomous B cell defect. Instead, the combination of these seemingly incompatible observations suggests that IgE levels may be higher in OVA-immunized Tpl2 mice contained significantly higher numbers of inflammatory cells, primarily eosinophils ( Fig. 2A) . The increased number of eosinophils in Tpl2 2/2 mice correlated with increased levels of eosinophil peroxidase (Fig. 2B) , suggesting that the eosinophils accumulating in the exudates were active. To investigate the mechanisms responsible for the differential recruitment of eosinophils, we proceeded to measure the bronchoalveolar exudate levels of molecules linked to eosinophil recruitment. The results showed that the chemokine eotaxin and IgE were both significantly higher in the exudates of Tpl2 2/2 mice (Fig. 2C, 2D ).
To further explore the mechanism of the enhanced allergic response of Tpl2 2/2 mice to OVA, we also examined the number of basophils in the blood and spleen and the number of mast cells in the skin and stomach of Tpl2 +/+ and Tpl2 2/2 mice. The results showed no significant differences. Similarly, there were no significant differences between Tpl2 +/+ and Tpl2 2/2 BMMCs development or IgE receptor (FceRIa) expression or functionally as measured by b-hexosaminidase release after IgE receptor crosslinking (Supplemental Fig. 1A-C) .
OVA challenge induces a stronger Th2 cytokine response in Tpl2 2/2 than in Tpl2 +/+ T cells
The results of our earlier studies, which were discussed previously, showed that the shift in the relative levels of Ig isotypes in OVAimmunized Tpl2 2/2 animals are not the result of major defects in lymphoid cell differentiation and distribution or to defects in B cell, basophil, and mast cell function. Given that increased levels of IgE have been linked to cytokines produced by Th2 cells (9) (10) (11) 48) , the question arose as to whether T cells from OVA-immunized Tpl2 2/2 mice produce predominantly Th2 cytokines when exposed to OVA. To address this question, we measured the levels of IL-4 and IL-5 (Th2 cytokines) in bronchoalevolar exudates from OVA-immunized or PBS-inoculated control mice. The same cytokines were measured in the supernatants of splenocyte cultures exposed to OVA. The results showed that brochoalveolar exudates from Tpl2 2/2 mice contain higher concentrations of IL-4 and IL-5
( Fig. 3A, 3B ). Culture supernatants of OVA-treated splenocytes from Tpl2 2/2 mice also contained higher levels of both IL-4 and IL-5 ( Fig. 3C, 3D ). These data suggested that Tpl2 ablation promotes the Th2 polarization of the immune response to OVA.
Tpl2 ablation gives rise to a T cell-intrinsic defect in Th cell differentiation that favors Th2 polarization
Exposure to Ag promotes T cell proliferation and expression of cytokines and other molecules involved in T cell activation. Theoretically, the polarization of the T cell response could be a T cell autonomous phenomenon, or it may be regulated by signals that originate in the APCs. Alternatively, it may depend on a combination of T cell autonomous and APC-dependent mechanisms. Therefore, Tpl2 ablation may be operating at the T cell level, at the APC level, or both. Experiments presented in this study provide evidence for an intrinsic T cell defect that favors Th2 polarization in Tpl2 2/2 mice. (Fig. 4A) . This experiment suggested that the Th2 polarization of the T cell response in Tpl2 2/2 mice could be mediated by T cell autonomous mechanisms. To confirm this conclusion, purified CD4 + T cells from WTor Tpl2 knockout mice were stimulated with plate-bound anti-CD3 and anti-CD28, which stimulate the T cells in an APC-independent manner. After 18 h, cytokine expression was measured by real-time RT-PCR. Tpl2 knockout CD4 + T cells expressed less IFN-g and slightly increased IL-4 compared with WT CD4 + T cells, both basally and after stimulation (Fig. 4B) . These data support the hypothesis that Tpl2 ablation gives rise to a T cell-intrinsic defect in Th cell differentiation, which causes a Th1/Th2 imbalance favoring the Th2 cells. Tpl2 therefore may promote T cell differentiation along the Th1 lineage and Tpl2 ablation may give rise to a Th1 differentiation defect.
To address the mechanism by which Tpl2 may affect the differentiation of Th cells, we first examined the expression of Tpl2 in cultured Th1 and Th2 cells from WT mice. Analysis of Th1 and Th2 polarized CD4 + T cells revealed that Th1 cells express higher (Fig. 5C) showed that Th1 cells from Tpl2 2/2 mice express greatly reduced levels of T-bet, whereas Th2 cells from the same mice express only slightly higher levels of GATA3 than Th2 cells of WT mice. These results suggest functional differences between Tpl2 2/2 and Tpl2 +/+ Th1 cells, and they are consistent with the results of earlier studies showing that the phosphorylation of STAT4 and the expression of IFN-g in TCR or IL-12-stimulated CD4 + T cells are Tpl2-dependent (42) . Overall, these data combined, suggest that Th1 cells developing from Tpl2 2/2 mice are functionally defective. Given that cytokines produced by Th1 cells promote Th1 cell differentiation, these findings also suggest that the functional defect of the Tpl2 2/2 Th1 cells contributes to the T cell autonomous Th2 polarization in Tpl2 2/2 mice.
The effect of Tpl2 ablation on APC function
The Th2 polarization of the Th cell response in Tpl2 2/2 mice may depend on T cell autonomous mechanisms, as suggested by the data presented previously, or a combination of T cell autonomous and APC-dependent mechanisms. The latter was suggested by a wealth of earlier data showing that the ablation of Tpl2 gives rise to functional defects in both macrophages and dendritic cells (36, 37, 40, 47) , also confirmed in the current study by measuring LPSor zymosan-induced cytokine production in BMDCs (data not shown). To address the role of APC-dependent mechanisms in Th2 polarization in Tpl2 knockout mice, we first examined the effects of Tpl2 ablation on the number of dendritic cells in the spleen of unimmunized animals. To this end, low-density spleen cells enriched in dendritic cells (49) Fig. 2A ). Further studies revealed that freshly isolated CD11c-positive dendritic cells from the spleen of Tpl2 +/+ and Tpl2 2/2 mice express similar levels of MHC class II, CD80, CD86, and CD40 (Supplemental Fig. 2B ). Finally, the induction of MHC class II, CD80, CD86, and CD40 was also similar in unfractionated WT and Tpl2 2/2 dendritic cells stimulated with LPS, zymosan, or polyinoinic-polycytidylic acid (Supplemental Fig. 3 ). (Fig. 6) . These data combined, support the hypothesis that T cell-expressed Tpl2 The data presented in this study are in agreement with the data in another recent report showing that Tpl2 ablation renders mice susceptible to T. gondii infection, because it interferes with the mounting of a protective Th1 response (42) . However, the data in both these papers differ from the data in another report, showing that Tpl2 ablation promotes the Th1 polarization of the T cell response in OVA-immunized mice (50) . The difference between our data and the data in the latter report may be caused by differences in the route of immunization. Thus, whereas our mice were immunized by i.p. injection of OVA mixed with alum, the mice in the latter report were immunized by footpad injection of OVA mixed with complete Freund's adjuvant, alum, or incomplete Freund's adjuvant, containing LPS or CpG DNA. Another confounding factor is that there may be differences in the genetic background of the Tpl2 2/2 mice in the two reports, which has been demonstrated to dramatically affect Th cell differentiation. Whereas the mice used in the current study were backcrossed nine times into the C57BL/6 genetic background, the Tpl2 2/2 mice in the earlier report were only in the sixth generation of backcrossing into the C57BL/6 background. The Th1/Th2 polarization of the Th cells depends on a combination of T cell intrinsic and APC-dependent mechanisms (51) . To determine the mechanism by which Tpl2 regulates this process, we first examined its contribution to T cell intrinsic mechanisms of Th cell polarization. To this end, we measured the secretion of IL-4 and IFN-g by splenocytes from naive Tpl2 +/+ and Tpl2 BMDCs from naive Tpl2 +/+ and Tpl2 2/2 mice were treated with an OVA peptide specific for the OT2 TCR transgene, and the expression of Th1 and Th2 cytokines was measured by ELISA. These experiments revealed that, whereas Tpl2 expression in T cells is required for the expression of Th1 and the suppression of Th2 cytokines, Tpl2 expression in dendritic cells affects the expression of these cytokines minimally, or not at all. These data confirmed that Tpl2 expression in T cells is critical for the differentiation of Th cells along the Th1 pathway after OVA immunization. In addition, they showed that, despite the fact that Tpl2 expressed in dendritic cells plays a major functional role in these cells, its contribution toward Th cell differentiation in response to OVA is minimal. In summary, the findings presented in this paper demonstrate that after immunization with T cell-dependent Ags, Tpl2 promotes the differentiation of CD4 + Th cells along the Th1 pathway primarily www.jimmunol.org via T cell intrinsic mechanisms. As a result, Tpl2 ablation promotes the Th2 polarization of the Th cell response and the development of allergy. The results of the current study may facilitate the design of preventive and therapeutic strategies for allergeninduced inflammation.
